The site encourages consumers sleeping pills to keep an eye out for false or misleading ads and provides a jasper to report violators. A service of YellowBrix, Inc.. Pharmaceutical ad spending they reckon on antibiotics tetracyclin no to exceed $5 billion sleeping pills a year is losing its potency.
Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Skell Law, lead That bodes ill for the magazines, estradiol antidepressant medications newspapers and radio and TV outlets for which the ads have been a prescription for profits. And it comes as they already are online pharmacy dealing with large spending declines in some other major ad categories, such as automotive and amoxycillin antibiotic amoxicillin telecommunications, and recession fears, thanks to the crisis on Wall Street. Rival ad tracker rozerem 8 mg Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion.
It launched a "Be Smart about Prescription Drug Advertising" area online at. "Throughout much of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers become more comfortable and experienced with DTC advertising," says Jon Swallen, rozerem for sleep TNS senior vice president of research. Some major brands, such as Pfizer's Lipitor, have revamped ads under government pressure. Sepracor's Lunesta, an insomnia drug known for its glowing moth icon, spent $75million on ads in the first quarter of 2008 vs. That if online pharmacy the government gets involved, they'll be worse off." Last month, the Food and Drug Administration stepped up its watch by asking consumers to help watch for false or misleading drug ads. Two recent reports say drugmakers cut Rx ad spending in the first six months of this year.
Those declines are an abrupt reversal from the robust spending growth of a few years ago. Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). Takeda Pharmaceuticals Southbound America's Rozerem sleep aid, which used offbeat ad characters such as Johny Granny and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year. "The pharmaceutical companies perceive the threat of government regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Among factors driving the drop, he says, are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. $175million in that quarter in 2007. TNS Media Intelligence puts the drop at 3.9% to $2.4 billion. The reports follow a well-publicized Harvard Medical School study that found consumer ads had little effect on prescription drug sales.
Magazines and radio stations have seen the most drug ad decline. (c) 2008 USA TODAY, a division of Gannett Co. Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million.
Researchers focused on ads for three drugs. By Maryjane Petrecca NEW YORK -- This could make media owners appalled.
.